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ABSTRACT: TCF12-related craniosynostosis can be
caused by small heterozygous loss-of-function mutations
in TCF12. Large intragenic rearrangements, however,
have not been described yet. Here, we present the iden-
tification of four large rearrangements in TCF12 causing
TCF12-related craniosynostosis. Whole-genome sequenc-
ing was applied on the DNA of 18 index cases with coronal
synostosis and their family members (43 samples in total).
The data were analyzed using an autosomal-dominant dis-
ease model. Structural variant analysis reported intragenic
exon deletions (of sizes 84.9, 8.6, and 5.4 kb) in TCF12
in three different families. The results were confirmed
by deletion-specific PCR and dideoxy-sequence analysis.
Separately, targeted sequencing of the TCF12 genomic
region in a patient with coronal synostosis identified a
tandem duplication of 11.3 kb. The pathogenic effect of
this duplication was confirmed by cDNA analysis. These
findings indicate the importance of screening for larger re-
arrangements in patients suspected to haveTCF12-related
craniosynostosis.
Hum Mutat 37:732–736, 2016. Published 2016 Wiley Periodi-
cals, Inc.∗
KEY WORDS: TCF12-related craniosynostosis; intragenic
exon deletion; exon duplication; rearrangements
Craniosynostosis is a condition in which the calvarial sutures are
fused prematurely. Fusion of the coronal sutures has the highest
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chance of having a specific genetic cause. In patients with coronal
synostosis, mutations are often found in FGFR2 (MIM #176943),
FGFR3 (MIM #134934), TWIST1 (MIM #601622), and EFNB1
(MIM #300035). Recently, however, another disease gene for coro-
nal synostosis, TCF12 (MIM #600480), has been identified [Sharma
et al., 2013]. The product of this gene is a member of the basic helix-
loop-helix E-protein family and forms heterodimers with TWIST1
[Connerney et al., 2006; Sharma et al., 2013].
In 32% and 10%, respectively, of patients with bicoronal and
unicoronal synostosis in whom other genetic testing was negative,
a pathogenic heterozygous mutation could be identified in TCF12
by dideoxy-sequencing [Sharma et al., 2013]. In addition to coro-
nal synostosis, patients can have craniofacial features suggestive of
Saethre–Chotzen syndrome, and a minority have developmental
delay and/or learning disabilities. On the other hand, a substantial
proportion (>50%) of individuals heterozygous for a pathogenic
TCF12mutations are nonpenetrant [Sharma et al., 2013].
In patients withTCF12-related craniosynostosis, pointmutations
are predominantly found [Sharma et al., 2013; di Rocco et al., 2014;
Paumard-Hernandez et al., 2014]. A few patients with craniosynos-
tosis and intellectual disability have been reported with large chro-
mosome 15q deletions including TCF12 [Fukushima et al., 1990;
Shur et al., 2003; Hiraki et al., 2008]. Recently, Le Tanno et al. (2014)
have described a heterozygous de novo deletion of 3.64 Mb due to
an unbalanced maternally inherited translocation in a patient with
coronal craniosynostosis and intellectualdisability. In addition, a72-
year-oldpatienthasbeen identifiedwith intellectual disability (with-
out clear signs of craniosynostosis) and a TCF12 microdeletion of
84–121 kb, removing exons 19–21 and extending 3′ from the end of
the gene [Piard et al., 2015]. Gross rearrangements with both break-
points lyingwithinTCF12, however, havenot beendescribed todate;
in the original report of TCF12 mutations, an assay for deletions
using multiplex-ligation-dependent probe amplification (MLPA)
found no rearrangements in 226 mixed craniosynostosis samples
negative for intragenic TCF12mutations [Sharma et al., 2013].
In this study,we describe the identification of three large inherited
intragenic exondeletions inTCF12usingwhole-genome sequencing
(WGS) and one large inherited duplication using targeted TCF12
sequencing.
C© 2016 The Authors Human Mutation Published by Wiley Periodicals, Inc.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the
original work is properly cited.
Table 1. Clinical Features of Families Harboring TCF12 Rearrangements
Family 1 Family 2 Family 3 Family 4
cDNA position of rearrangement c.391–5871 1746–1795del c.1745 + 4562 1978 + 3153del c.1979–3147 ∗12–1497del c.1746–1697 ∗11 + 65dup
Size of rearrangement (kb) 84.9 8.6 5.4 11.3
Exons involved 7–18 19 20 19 and 20
Type of rearrangement Deletion Deletion Deletion Duplication
Gender of index patient Male Female Male Male
Gestational age (weeks) 37+6 42+4 39+4 38
Birth weight (grams) 3,075 3,620 3,365 NA
Cranial suture fusion RC BC All except M BC
Major craniofacial procedures Fronto-supraorbital
remodeling @ 10 months
Supraorbital advancement @
9 months
Fronto-biparietal remodeling
@ 8 months,
parieto-occipital
decompression @ 2 years
FOAR @ 10.5 months
Development Mild learning problems VIQ
82, PIQ 64, GIQ 74
Normal Normal Normal
Limbs Fifth finger camptodactyly Normal Normal Fifth finger clinodactyly
Other major clinical features Divergent strabismus,
recurrent infections, febrile
seizures
Myopia, crowding of teeth,
divergent growth pattern
Increased ICP Class II.1 malocclusion, small ears
with prominent helical crura
Family history Mother LC Sister of father brachycephaly Negative Flattened foreheads in maternal
half-brother and his daughter
Previous genetic diagnostics Karyotyping, FGFR2, FGFR3,
TWIST1, TCF12
FGFR2, FGFR3, TWIST1,
TCF12
FGFR2, FGFR3, TWIST1 FGFR2, FGFR3, TWIST1, TCF12
Subjects sequenced II.1, II.2, and III.1 II.1, II.2, II.3, and III.1 II.1, II.2, and III.2 III.1
BC, bicoronal; FOAR, fronto-orbital advancement and remodeling; GIQ, Global IQ; LC, left coronal; M, metopic; PIQ, performal IQ; RC, right coronal; VIQ, verbal IQ.
Within the framework of a broader study into the genetic causes
of craniosynostosis, WGS was applied to DNA of 18 Dutch in-
dex cases with coronal synostosis and negative testing for FGFR2,
FGFR3, and TWIST1, and their family members (43 samples in to-
tal), by Complete Genomics, a BGI company (Mountain View, CA),
as described in Drmanac et al. (2010). The data were analyzed using
an autosomal-dominant disease model. Structural variant analysis
using a custom made Python script [Gilissen et al., 2014] reported
different large intragenic exon deletions of TCF12 in three families
(families 1, 2, and 3). The clinical features of the families are sum-
marized in Table 1 and pedigrees and full subject descriptions are
provided in the Supp. Materials and Methods (Supp. Fig. S1 and
subject descriptions, respectively).
A heterozygous 84,949 bp deletion was reported in family 1,
starting at chr15:57478485 and ending at chr15:57563433 (c.391-
5871 1746-1795del) in DNA of the index patient and his mother
(using reference NM 207037.1 on GRCh37). Exons 7–18 were
deleted. In family 2, a heterozygous deletion of 8,580 bp was re-
ported, starting at chr15:57560034 and ending at chr15:57568613
(c.1745+4562 1978+3153del) in DNA of the index patient, the clin-
ically unaffected father and affected paternal aunt. The deletion
removed exon 19. In family 3, a heterozygous 5,363 bp deletion was
reported, starting at chr15:57571496 and ending at chr15:57576858
(c.1979-3147 ∗12-1497del) inDNAof the index patient andhis clin-
ically unaffected mother. This deleted exon 20. The three deletions
were not seen in control samples (i.e., Structural Variation Baseline
Genome Set comprising 52 baseline genomes used by Complete
Genomics and 588 Wellderly samples [Scripps Wellderly Genome
Resource, The Scripps Wellderly Study, La Jolla, CA [December,
2015]], funding provided by Scripps Health and NIH/NCATS UL1
TR00114).
Deletion-specific PCRs were designed to confirm the findings by
WGS (Fig. 1 A–E). In family 1, the mutant PCR product of 644 bp
was present in II.2 and III.1 (Fig. 1B, lanes 2–4, and C). An anal-
ysis of the normal sequence showed that the proximal breakpoint
resided in an AluJb element, whereas the distal breakpoint was lo-
cated in a L1P2 repetitive element. The sequences of the breakpoints
showed no significant similarity except for a shared 4 bp GAGC
motif. In family 2, themutant PCR product of 556 bp was present in
II.1, II.2, and III.1 (Fig. 1B, lanes 5–8, and D). The proximal break-
point was located in an MIRb element and the distal breakpoint in
a HAL1 element. The sequences showed no significant similarity,
except for a shared cytosine. In family 3, the mutant PCR product
of 646 bp was present in II.2 and III.2 (Fig. 1B, lanes 9–11, and E).
The proximal breakpoint also resided in a HAL1 element; the dis-
tal breakpoint was not located in a repetitive element. However, an
AluSz repeat was located 151 bp centromeric of the distal breakpoint
and an MIRb 789 bp telomeric. The sequences of the breakpoints
showed no significant similarity. Amplification of patient cDNA
of family 3 with primers located in exon 18 and 3′ UTR (exon
21) showed an extra smaller product, absent in control cDNA. Se-
quencing of the smaller-sized product indicated skipping of exon 20
(Supp. Fig. S2).
In parallel to this work, targeted sequencing of DNA samples
of 160 British unrelated subjects with craniosynostosis, including
the coronal suture, and previously negative testing of the FGFR2,
FGFR3, TWIST1, and TCF12 genes, was carried out by capturing
theTCF12 genomic region (chr15: 57,029,979-57,670,037) using the
SeqCap EZ Choice Library system (Roche-Nimblegen, Inc., Madi-
son,WI). Using analysis with Pindel [Ye et al., 2009], a heterozygous
tandemduplicationwas called in the index patient of family 4 (pedi-
gree in Supp. Fig. S1D (II.1)).
Breakpoint spanning PCR (using primers orientated in opposite
directions in the wild-type sequence, shown in Supp. Table S1)
showed a mutant PCR product from genomic DNA of both the
index patient and his clinically unaffectedmother (Fig. 1F). Dideoxy
sequencing confirmed a tandem duplication of 11,331 base pairs,
starting at chr15:57563531 and ending at chr15:57574861 (c.1746-
1697 ∗11+65dup) in the DNA of the index patient of family 4. The
duplication included TCF12 exons 19 and 20.
An analysis of the normal sequence showed that the proximal
breakpoint was located in an L1P2 repetitive element, whereas the
distal breakpoint did not reside in a repetitive element. Further,
sequence analysis revealed the presence of anMER1ADNAsequence
678 bp centromeric of the distal breakpoint, and the presence of an
AluSx element and a simple tandem repeat at 597 and 1,165 bp,
HUMANMUTATION, Vol. 37, No. 8, 732–736, 2016 733
Figure 1. Rearrangements identified in TCF12. A–E: Confirmation of deletions. A primer design. F1, forward primer; R1, reverse primer 1; R2,
reverse primer 2. F1+R1, wild-type allele (WT); F1+R2, mutant allele (). B: Results of mutation-specific deletion PCR analysis. Lane 1, negative
control. Lanes 2–4, family 1; wild-type fragment 1,455 bp, mutant fragment 644 bp; lane 2, II.1; lane 3, II.2; lane 4, III.1. Lanes 5–8, family 2; wild-type
fragment 1,107 bp, mutant fragment 556 bp; lane 5, II.1; lane 6, II.2; lane 7, II.3; lane 8, III.1. Lanes 9–11, family 3; wild-type fragment 1,303 bp, mutant
fragment 646 bp; lane 9, II.1; lane 10, II.2; lane 11, III.2. C–E: Electropherograms of dideoxy sequence analysis. C: Mutant allele in family 1, exons 7–18
deleted. D: Mutant allele in family 2, exon 19 deleted. E: Mutant allele in family 3, exon 20 deleted. Dashed lines indicate where deletions occurred.
F–J: Confirmation of duplication. F: PCR from genomic DNA confirming the presence of duplication in index patient of family 4 (III.1), which was
inherited from the index patient’s clinically unaffected mother (II.2). G: The sequence at the duplication breakpoint is sandwiched between the
normal proximal (above) and distal (below) sequences, with the electropherogram underneath (H). I: cDNA amplified from the index patient (III.1)
with primers specific to the mutant allele. Two different products were visible on the gel (but absent in two control cDNA samples). J: Sequencing
of these products indicated splicing from exon 20 to the duplicated exon 19 in the smaller-sized product (lower electropherogram). The larger
product (upper electropherogram) contains an additional 35 nucleotide neo-exon between exons 20 and 19. The normal stop codon in exon 20 is
highlighted.
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respectively, telomeric of the distal breakpoint. The sequences of the
breakpoints shared an AG dinucleotide (Fig. 1G).
Amplification of patient cDNA with primers located in exon 18
and 3′ UTR (therefore spanning the duplication) showed only a sin-
gle product corresponding to the wild-type allele (data not shown).
This suggested that the product from the duplicated allele might be
expressed at a relatively low level, although bias in PCR amplifica-
tion favoring the smaller wild-type product could not be excluded.
We therefore designed a pair of primers in exon 19, orientated in
opposite directions, predicted to generate a product only from the
duplicated allele. Electrophoresis of PCR products revealed two rel-
atively weak fragments in the patient cell line, absent in two controls
(Fig. 1I). Sequencing of the smaller-sized product indicated splicing
from exon 20 to the duplicated exon 19, whereas the larger product
contained additional neo-exon sequence of 35 bp, originating from
within the intron 18–19 sequence (Fig. 1J).
In summary, we have identified the first intragenic duplication
and deletions withinTCF12 in patients with craniosynostosis. These
findings demonstrate the importance of screening, not only for
point mutations and small indels in TCF12, but also for larger
rearrangements.
In patients with nonsyndromic and syndromic bicoronal or uni-
coronal synostosis, FGFR2, FGFR3, and TWIST1 are often tested
routinely for mutations. In approximately 28% of the craniosyn-
ostosis patients (with any combination of sutures fused) having a
genetic cause, a pathogenic mutation can be identified in FGFR2, in
19% of the patients in FGFR3, and in 16% in TWIST1. TCF12 in-
tragenic mutations cause approximately 4% of these cases [Sharma
et al., 2013].
To date, we have tested, by dideoxy-sequencing of TCF12, 105
Dutch syndromic and nonsyndromic coronal craniosynostosis in-
dex patients with negative results for FGFR2, FGFR3, and TWIST1
testing. This led to the identification of 22 TCF12mutation-positive
index cases (including 14 cases that were previously described by
Sharma et al. (2013).We now report the identification of gross dele-
tions of TCF12 in three out of 18 index cases that were analyzed by
WGS (in five cases a mutation was found in another gene). Further-
more, we describe a gross TCF12 duplication in a further patient
with coronal synostosis, using targeted sequencing of the TCF12
genomic region.
The identification ofTCF12deletions in two of theDutch patients
(families 1 and 2) was a particular surprise, because these patients
had been included in the negative MLPA analysis (zero positive
from 226 samples) previously reported by Sharma et al. (2013). Re-
examination of the rawMLPAdata revealed that the analysis had not
been performed correctly, and both deletions were in fact evident.
Further scrutiny of the remaining MLPA data revealed an Oxford
sample that harbored a deletion of exons 5–19, which was indepen-
dently found in the TCF12 capture sequencing data (not shown).
Hence, it is evident thatTCF12 deletions contributemore frequently
to coronal synostosis thanpreviously thought; combining the results
of WGS (3/13) and the reanalyzed MLPA dataset (1/95), four of 108
(3.7%) individuals with this diagnosis and previously negative for
standard genetic testing, were found to have deletions. Overall, three
out of 25Dutch cases ofTCF12-related craniosynostosiswere caused
by large, intragenic TCF12 rearrangements.
Analyzing thebreakpoint sequences, it appears that the rearrange-
ments occur in, or in the proximity of, repeat sequences (family 1
AluJb SINE and L1P2 LINE element; family 2MIRb SINE andHAL1
LINE; family 3 HAL1 LINE and in proximity of AluSz SINE/MIRb
SINE; family 4 L1P2LINE and in proximity ofMER1A/AluSx SINE).
Furthermore, the sequences of the breakpoints show no significant
similarity (family 1 four-nucleotide homology; family 2 one shared
nucleotide; family 3 none; family 4 two shared nucleotides). The
nonobligatory presence of terminal microhomology and repeat se-
quences indicates classical nonhomologous end joining as the most
likely mechanism [Stankiewicz et al., 2003; Gu et al., 2008; Chen
et al., 2010].
All but one previously described pathogenic mutations are lo-
cated in the 3′ half of TCF12 (exons 9–19) [Sharma et al., 2013].
The first two deletions also include this region of the gene (fam-
ily 1 exons 7–18 and family 2 exon 19). The deletion in family 1
contains regions of TCF12 encoding the activation domain 2 and
the rep domain. In family 2, the region encoding the functionally
important basic helix-loop-helix domain is included [Zhang et al.,
1991; Aronheim et al., 1993; Markus et al., 2002]. These domains
are still present in the mutant alleles in families 3 and 4. cDNA
studies indicate skipping of exon 20 in family 3 (Supp. Fig. S2).
Although the duplicated allele in family 4 should retain the capac-
ity to translate the full-length protein, the cDNA studies (Fig. 1G)
indicate that this transcript is likely unstable, causing functional
haploinsufficiency. The rearrangements in families 3 and 4 are the
first mutations described that lie 3′ of the region that encodes the
bHLH domain.
While the deletion in family 1 is 10-fold larger than that in family
2 and removes two functional domains of TCF12, the clinical cran-
iofacial features of the index patient of family 1 are not more severe
than the features of the index patient of family 2. The index patient
of family 1 has unicoronal synostosis, whereas the index patient of
family 2 and her aunt have bicoronal synostosis. The index patient
of family 1, however, does have mild learning disability. The most
severe phenotype in our study is seen in the index patient of family 3
(synostosis of almost all sutures and increased intracranial pressure),
though the smallest deletion is present in this family. Although the
index patient of family 4 has a duplication partially overlapping the
deleted regions of both family 2 and themore severely affected family
3, he only shows bicoronal synostosis andminor anomalies like fifth
finger clinodactyly. Clinodactyly and brachydactyly (present in his
mother) have previously been described in association with TCF12
mutations [Sharma et al., 2013; di Rocco et al., 2014]. Overall, the
findings do not reveal any genotype–phenotype correlation.
The index patient of family 3 does not exhibit the classical clin-
ical phenotype of TCF12-related craniosynostosis, since all vault
sutures were fused except for the metopic suture. Only two patients
have been described previously with synostosis of the coronal su-
tures combined with synostosis of the sagittal suture [Sharma et al.,
2013]. Also, the patient had papilledema postoperatively, indicating
increased intracranial pressure. Toour knowledge, this is the first pa-
tient described with TCF12-related craniosynostosis and increased
intracranial pressure postoperatively.
In conclusion, the clinical features of the index patients of
family 1, 2, and 4 fit the phenotype of TCF12-related craniosyn-
ostosis as described by Sharma et al. (2013). The reduced pene-
trance described previously is seen in three of our families as well.
Our study demonstrates that TCF12-related craniosynostosis can
also be caused by large intragenic rearrangements and that there
is no indication of a genotype–phenotype correlation. Therefore,
mutation analysis of TCF12 should also include a search for larger
rearrangements.
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